Location: Home
  • search
  • go
  • Relate News
  • 4/15/2017Recent Executive Moves
  • 4/15/2017NDRC Plans to Remove Hospital Drug Sales Margins in All Public Hospita...
  • 4/15/2017Bayer Saw Steady Growth of Its Prescription Medicine Business Last Yea...
  • 4/13/2017CDE Publicizes List of Drug Applications To Be Granted Priority Review...
  • 4/13/2017CDE Solicits Public Comments on Six TCM Technical Guidelines
  • 4/13/2017CFDA Issues New Announcement (2017#42) for Clinical Data Self-Inspecti...
  • 4/13/2017State Council Pushes Forward Infrastructural Building of Medical Conso...
  • 4/13/2017Chinese Journal Publishes the Findings of Largest Phase IV Trial of Ty...
  • 4/12/2017Summary of Drug Registration Evaluation and Approval in the Past Five ...
  • 4/12/2017Top TCs and Drug Suppliers to Chinese Hospitals 2016
  • 4/12/201732 Chinese Pharma Billionaires on 2016 Forbes Rich List
  • 4/11/2017China to Introduce Interpretations for Application of Criminal Laws fo...
  • 4/11/2017Shenzhen Makes Corrections after NDRC Finds the City's GPO Reform in V...
  • 4/11/2017CBMG and GE Healthcare Announce Partnership to Establish Joint Lab to ...
  • 4/11/2017IBM and Hejia Launch Supply Chain Financial Services Platform for Phar...
  • 4/10/2017CFDA Solicits Comments on 2nd Draft of Document for Handling of Clinic...
  • 4/10/2017GE, Zai Lab Enter Partnership to Co-Develop Biotherapeutics Clinical P...
  • 4/7/2017U.S. FDA Warns Jinda Pharma for Data Integrity Violations
  • 4/7/2017CFDA and NHFPC Publish Their 2017 Budgets
  • 4/7/2017CDE Accepted 871 Drug Registration Applications in Q1/2017
  • 4/7/2017MSD Renews Distribution Agreement with Zhifei for Two Vaccines
  • 4/7/2017Upcoming Event: Pharma China Annual Forum 2017 in Shanghai on April 14
  • 4/6/2017Fresenius Acquires Majority of Private Hospital in Kunming
  • 4/6/2017CBMG Expands cGMP Biologic Manufacturing Facility in Wuxi
  • 4/6/2017Recent Executive Moves
  • 4/6/2017NHFPC, CFDA Issue Joint Notice to Strengthen Filing and Regulation of ...
  • 4/6/2017CFDA Approves JHL's IND for Clinical Trial of Rituximab Biosimilar
  • 4/5/2017CFDA Issues Document for Product Classification under Generic Drug Equ...
  • 4/5/2017CFDA Announce Decision to Adjust Certain Drug Approval Processes
  • 4/5/2017USFDA Warns Lumis Global Pharma of cGMP Deficiencies
  • Page:368/776 Total number of articles:23279: [First][<<] [366] [367] [368] [369] [370] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group